Single User License
INR 100245
Site License
INR 200490
Corporate User License
INR 300735

Service Tax Additional

select a format
Price

Single User License
USD 1500
Site License
USD 3000
Corporate User License
USD 4500

Alternatively

Request a quote
Request a Customized research
Request for Sample Report





Recent Viewed Reports


Why Ken Reasearch?


Testimonials

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ... "Prashant Bhagwat,General Manager, Mahindra"

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!... "Jestin Mathew, Indonesian Trade Promotion Center"

The Report was very interesting and useful for me... "Marketing Manager, Western Union Business Solutions"

Ken Research completed the report successfully with tough deadline and large requirement. Really appreciate it... "Sales Manager, Largest India Aesthetic Laser Manufacturer"

We found the report really useful in understanding the complex Indian market and it provided lots of high quality insights. On the basis of this we commissioned Ken to produce a bespoke follow up to answer some specific questions about our market. This is now being used to help develop our marketing and sales strategy. We were very pleased with the comprehensive coverage, detail provided and actionable insights.... "Owner, Therefore Consulting UK"


Kuhnil Pharmaceutical Co., Ltd.-Product Pipeline Review-2015

Kuhnil Pharmaceutical Co., Ltd.-Product Pipeline Review-2015


  • Products Id :- GMDHC07270CDB
  • |
  • Pages: 38
  • |
  • July 2015
  • |
  • |
  Request for Sample Report

Executive Summary

Kuhnil Pharmaceutical Co., Ltd.-Product Pipeline Review-2015

Summary

Global Markets Direct's, 'Kuhnil Pharmaceutical Co., Ltd.-Product Pipeline Review-2015', provides an overview of the Kuhnil Pharmaceutical Co., Ltd.'s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Kuhnil Pharmaceutical Co., Ltd.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

The report provides brief overview of Kuhnil Pharmaceutical Co., Ltd. including business description, key information and facts, and its locations and subsidiaries

The report reviews current pipeline of Kuhnil Pharmaceutical Co., Ltd.'s human therapeutic division and enlists all their major and minor projects

The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones

Special feature on out-licensed and partnered product portfolio

The report summarizes all the dormant and discontinued pipeline projects

Latest company statement

Latest news and deals relating to the Kuhnil Pharmaceutical Co., Ltd.'s pipeline products

Reasons To Buy

Evaluate Kuhnil Pharmaceutical Co., Ltd.'s strategic position with total access to detailed information on its product pipeline

Assess the growth potential of Kuhnil Pharmaceutical Co., Ltd. in its therapy areas of focus

Identify new drug targets and therapeutic classes in the Kuhnil Pharmaceutical Co., Ltd.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas

Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps

Develop strategic initiatives by understanding the focus areas of Kuhnil Pharmaceutical Co., Ltd. and exploit collaboration and partnership opportunities

Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

Plan mergers and acquisitions effectively by identifying the most promising pipeline of Kuhnil Pharmaceutical Co., Ltd.

Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

Explore the dormant and discontinued projects of Kuhnil Pharmaceutical Co., Ltd. and identify potential opportunities in those areas

Avoid Intellectual Property Rights related issues

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 4

Kuhnil Pharmaceutical Co., Ltd. Snapshot 5

Kuhnil Pharmaceutical Co., Ltd. Overview 5

Key Information 5

Key Facts 5

Kuhnil Pharmaceutical Co., Ltd.-Research and Development Overview 6

Key Therapeutic Areas 6

Kuhnil Pharmaceutical Co., Ltd.-Pipeline Review 8

Pipeline Products by Stage of Development 8

Pipeline Products-Monotherapy 9

Pipeline Products-Partnered Products 10

Partnered Products/Combination Treatment Modalities 11

Kuhnil Pharmaceutical Co., Ltd.-Pipeline Products Glance 12

Kuhnil Pharmaceutical Co., Ltd.-Late Stage Pipeline Products 12

Phase III Products/Combination Treatment Modalities 12

Kuhnil Pharmaceutical Co., Ltd.-Clinical Stage Pipeline Products 13

Phase II Products/Combination Treatment Modalities 13

Phase I Products/Combination Treatment Modalities 14

Kuhnil Pharmaceutical Co., Ltd.-Early Stage Pipeline Products 15

Preclinical Products/Combination Treatment Modalities 15

Discovery Products/Combination Treatment Modalities 16

Kuhnil Pharmaceutical Co., Ltd.-Drug Profiles 17

KI-0501 17

Product Description 17

Mechanism of Action 17

R&D Progress 17

nimotuzumab 18

Product Description 18

Mechanism of Action 18

R&D Progress 18

KI-0503 21

Product Description 21

Mechanism of Action 21

R&D Progress 21

KI-1102 22

Product Description 22

Mechanism of Action 22

R&D Progress 22

KI-1104 23

Product Description 23

Mechanism of Action 23

R&D Progress 23

KI-0801 24

Product Description 24

Mechanism of Action 24

R&D Progress 24

KI-1002 25

Product Description 25

Mechanism of Action 25

R&D Progress 25

KI-1003 26

Product Description 26

Mechanism of Action 26

R&D Progress 26

KI-1007 27

Product Description 27

Mechanism of Action 27

R&D Progress 27

KI-1101 28

Product Description 28

Mechanism of Action 28

R&D Progress 28

KI-1103 29

Product Description 29

Mechanism of Action 29

R&D Progress 29

KI-1105 30

Product Description 30

Mechanism of Action 30

R&D Progress 30

Kuhnil Pharmaceutical Co., Ltd.-Pipeline Analysis 31

Kuhnil Pharmaceutical Co., Ltd.-Pipeline Products by Target 31

Kuhnil Pharmaceutical Co., Ltd.-Pipeline Products by Route of Administration 32

Kuhnil Pharmaceutical Co., Ltd.-Pipeline Products by Molecule Type 33

Kuhnil Pharmaceutical Co., Ltd.-Pipeline Products by Mechanism of Action 34

Kuhnil Pharmaceutical Co., Ltd.-Recent Pipeline Updates 35

Kuhnil Pharmaceutical Co., Ltd.-Locations And Subsidiaries 36

Head Office 36

Other Locations & Subsidiaries 36

Appendix 37

Methodology 37

Coverage 37

Secondary Research 37

Primary Research 37

Expert Panel Validation 37

Contact Us 37

Disclaimer 38

List of Tables

Kuhnil Pharmaceutical Co., Ltd., Key Information 5

Kuhnil Pharmaceutical Co., Ltd., Key Facts 5

Kuhnil Pharmaceutical Co., Ltd.-Pipeline by Indication, 2015 7

Kuhnil Pharmaceutical Co., Ltd.-Pipeline by Stage of Development, 2015 8

Kuhnil Pharmaceutical Co., Ltd.-Monotherapy Products in Pipeline, 2015 9

Kuhnil Pharmaceutical Co., Ltd.-Partnered Products in Pipeline, 2015 10

Kuhnil Pharmaceutical Co., Ltd.-Partnered Products/ Combination Treatment Modalities, 2015 11

Kuhnil Pharmaceutical Co., Ltd.-Phase III, 2015 12

Kuhnil Pharmaceutical Co., Ltd.-Phase II, 2015 13

Kuhnil Pharmaceutical Co., Ltd.-Phase I, 2015 14

Kuhnil Pharmaceutical Co., Ltd.-Preclinical, 2015 15

Kuhnil Pharmaceutical Co., Ltd.-Discovery, 2015 16

Kuhnil Pharmaceutical Co., Ltd.-Pipeline by Target, 2015 31

Kuhnil Pharmaceutical Co., Ltd.-Pipeline by Route of Administration, 2015 32

Kuhnil Pharmaceutical Co., Ltd.-Pipeline by Molecule Type, 2015 33

Kuhnil Pharmaceutical Co., Ltd.-Pipeline Products by Mechanism of Action, 2015 34

Kuhnil Pharmaceutical Co., Ltd.-Recent Pipeline Updates, 2015 35

Kuhnil Pharmaceutical Co., Ltd., Other Locations 36

List of Figures

Kuhnil Pharmaceutical Co., Ltd.-Pipeline by Top 10 Indication, 2015 7

Kuhnil Pharmaceutical Co., Ltd.-Pipeline by Stage of Development, 2015 8

Kuhnil Pharmaceutical Co., Ltd.-Monotherapy Products in Pipeline, 2015 9

Kuhnil Pharmaceutical Co., Ltd.-Partnered Products in Pipeline, 2015 10

Kuhnil Pharmaceutical Co., Ltd.-Pipeline by Top 10 Molecule Type, 2015 33

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com
 

Current R&D Portfolio of Kuhnil Pharmaceutical Co., Ltd.; Kuhnil Pharmaceutical Co., Ltd. - Key Therapeutics; Kuhnil Pharmaceutical Co., Ltd. - Pipeline Overview and Promising Molecules; Kuhnil Pharmaceutical Co., Ltd. - News; Kuhnil Pharmaceutical Co., Ltd. - Latest Updates; Kuhnil Pharmaceutical Co., Ltd. - Pipeline; Kuhnil Pharmaceutical Co., Ltd. - Discontinued/Dormant Projects


Related Products in vertical
Other reports by publisher
Ken Research Pvt. Ltd. 27A, Tower B-2, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India
+91 1244230204

download

Company Brochure

Engage with Us

query [@] kenresearch.com